A digital version of the NHS Health Check for 40- to 74-year-olds is to be piloted by the government as a way to lessen pressure on the nation’s GP services. The NHS Health Check is designed to identify early signs…
Novartis builds case for iptacopan as oral rival to PNH injectables
Novartis has a second positive phase 3 trial in the bag for its targeted factor B inhibitor iptacopan, vying to become an oral alternative to injectable therapies for ultra-rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH). The Swiss pharma group said…
ImmunoGen and Gilead Team Up to Target AML
ImmunoGen entered into a clinical collaboration deal with Gilead Sciences Friday to evaluate the safety and efficacy of two drugs that, when used in concert, have the potential to treat AML, a blood disorder biopharma has found challenging to target. …
US FDA grants clearance to commence trials of Sorrento’s mRNA vaccine
The microneedle system, along with an mRNA vaccine candidate, showed enhanced humoral immunity in animal models. The US Food and Drug Administration (FDA) has granted clearance to Sorrento Therapeutics to commence clinical trials of the messenger ribonucleic acid (mRNA) vaccine STI-1557. Targeting…
Phanes and BeiGene partner for advanced solid tumour therapy trial
The trial will assess the combination of Phanes’ PT199 and BeiGene’s tislelizumab to treat advanced solid tumours. Phanes Therapeutics has signed a clinical supply agreement with BeiGene for assessing a PT199 and tislelizumab combination in a Phase I clinical trial…
Health Canada grants CTA authorisation for QurAlis’ ALS therapy
Assessing the safety and tolerability of varying doses of QRL-201 in ALS patients is the primary objective of the trial. Health Canada has granted authorisation for the clinical trial application (CTA ) of QurAlis for the Phase I ANQUR trial of its…
Walmart offers $3.1bn to settle opioid epidemic lawsuits
Walmart has become the latest big pharmacy chain in the US to put forward a settlement to resolve claims it contributed to the national opioid crisis by failing to regulate prescriptions at its outlets. The retail giant has confirmed it…
FDA grants IND clearance for NeuroSense’s Phase IIb ALS trial
The trial is designed to evaluate the efficacy, safety, and tolerability of PrimeC in ALS patients. The US Food and Drug Administration (FDA) has granted clearance for NeuroSense Therapeutics’ Investigational New Drug (IND) application to enrol patients in the country in its…
Experimental breast cancer vaccine proves safe in phase 1 clinical trials
Breast cancer is currently the most frequently diagnosed cancerTrusted Source in the United States, and globally it is the world’s most prevalent cancer. According to new phase 1 clinical trial data, a new plasmid DNA-based vaccine that is able to…
OneStudyTeam and Antidote partner to boost recruitment in trials
StudyTeam follows trial subjects through to enrolment and offers visibility to sponsors at each step of the enrolment process. OneStudyTeam has signed a collaboration with Antidote Technologies to offer an integrated, end-to-end patient referral management approach to sites and sponsors…
